Recently,⁤ Roy schoenberg, the long-serving CEO of AmWell, made a critically important ‍announcement in the New England Journal ⁣of⁣ Medicine regarding the development of an AI companion for seniors named Aileen.‌ We explored the current landscape of digital health, delving into recent developments at AmWell and⁤ examining the objectives behind this innovative AI initiative. Even though it is indeed still in its infancy, Roy presents a compelling vision for how artificial intelligence could serve as a foundational ‍tool to ⁢enhance the experience of elderly consumers. Engaging with Roy is always‍ enlightening, and this discussion was no exception–Matthew ⁣Holt